← back to search

E. Brian Butler

Methodist Hospital · US
Area of research
Pulmonary and Respiratory Medicine · Radiation
Research interest
Research interests include Advanced Radiotherapy Techniques, Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research, and Virus-based gene therapy research.
h-index
40
citations
6,450
works
343
NIH funding
primary concept
email

Recent publications

Re-treatment of locally recurrent uveal melanoma with repeat eye plaque I-125 brachytherapy: A single institution experience
Brachytherapy 2024cited by 2position: contributordoi
Prognostic impact of biologically equivalent dose in stereotactic body radiotherapy for renal cancer
Clinical and Translational Radiation Oncology 2023cited by 2position: contributordoi
Data from A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and <i>In Situ</i> Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer
2023cited by 0position: contributordoi
Supplementary Table from A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and <i>In Situ</i> Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer
2023cited by 0position: contributordoi
Supplementary Table from A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and <i>In Situ</i> Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer
2023cited by 0position: contributordoi
Supplementary Table from A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and <i>In Situ</i> Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer
2023cited by 0position: contributordoi
Data from A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and <i>In Situ</i> Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer
2023cited by 0position: contributordoi
Supplementary Table from A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and <i>In Situ</i> Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer
2023cited by 0position: contributordoi
Supplementary Table from A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and <i>In Situ</i> Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer
2023cited by 0position: contributordoi
Supplementary Table from A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and <i>In Situ</i> Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer
2023cited by 0position: contributordoi
Supplementary Table from A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and <i>In Situ</i> Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer
2023cited by 0position: contributordoi
Supplementary Figure from A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and <i>In Situ</i> Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer
2023cited by 0position: contributordoi
Supplementary Figure from A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and <i>In Situ</i> Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer
2023cited by 0position: contributordoi
Supplementary Table from A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and <i>In Situ</i> Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer
2023cited by 0position: contributordoi
Supplementary Figure from A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and <i>In Situ</i> Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer
2023cited by 0position: contributordoi
Supplementary Figure from A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and <i>In Situ</i> Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer
2023cited by 0position: contributordoi
A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and <i>In Situ</i> Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer
Clinical Cancer Research 2022cited by 36position: middledoi
A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer.
2022cited by 28position: contributordoi
Potentiating Antitumor Efficacy Through Radiation and Sustained Intratumoral Delivery of Anti-CD40 and Anti-PDL1
International Journal of Radiation Oncology*Biology*Physics 2020cited by 70position: middledoi
Patterns of care and outcomes of multi-agent versus single-agent chemotherapy as part of multimodal management of low grade glioma
Journal of Neuro-Oncology 2017cited by 50position: middledoi
Definitive chemoradiation at high volume facilities is associated with improved survival in glioblastoma
Journal of Neuro-Oncology 2017cited by 49position: middledoi

Grants

UNS: Dynamics and Rheology of Concentrated Suspensions of Rigid Rods: Effects of Confinement
NSF1511787$301,6782015–2021PIRePORTER
Workshop on Multiphase Continuum Modeling of Particulate Flows, December 9-11, 2015, Gainesville, FL
NSF1602937$15,0002015–2016PIRePORTER
Hydrodynamic effects on electrophoresis of biopolymers
NSF1067072$309,5462011–2015PIRePORTER
HBCU-UP: ASPIRE (Advancing Spelman College's Participation in INFORMATICS Research and Education) Project
NSF0714553$2,539,2482007–2014PIRePORTER
Role of the Ileal Peyers Patches in Neonatal Development
NSF0718754$482,2542007–2011PIRePORTER
CAREER: Dynamics, Rheology, and Microrheology of Rigid Polymers and Brownian Fibers
NSF0348205$400,0002004–2009PIRePORTER
B Cell Lymphogenesis in the Fetal Piglet
NSF0077237$490,0002000–2005PIRePORTER
U.S.-Czech Research on Antibody Repertoire Development in Fetal and Neonatal Piglet
NSF9904130$38,7901999–2004PIRePORTER
B Cell Lymphogenesis in the Fetal Piglet
NSF9723721$354,0681997–2001PIRePORTER
Student Science Training
NSF8024135$37,3821981–1981PIRePORTER
Student Science Training
NSF7827686$32,5501979–1979PIRePORTER
Student Science Training For High Ability Secondary School Students
NSF7727483$30,2001978–1978PIRePORTER
Student Science Training
NSF7700213$29,2901977–1977PIRePORTER

Frequent collaborators

Bin S. Teh · Houston Methodist4 papers (2017–2022)Yitian Xu · Shanghai Jiao Tong University2 papers (2020–2022)Licheng Zhang · Fudan University2 papers (2020–2022)Vivek Verma · AstraZeneca (Canada)2 papers (2017–2017)Waqar Haque · The University of Texas Medical Branch at Galveston2 papers (2017–2017)Shu-Hsia Chen · Houston Methodist2 papers (2020–2022) · 2 papers (2023–2024)Jenny C. Chang · Houston Methodist1 papers (2022–2022)Susan L. Haley · Methodist Hospital1 papers (2022–2022)Alessandro Grattoni · Houston Methodist1 papers (2020–2020)Sunil Mathur · Houston Methodist1 papers (2022–2022)Joe Ensor · Houston Methodist1 papers (2022–2022)Nathanael Hernandez · Houston Methodist1 papers (2020–2020)Carlo Guerrero · Houston Methodist1 papers (2022–2022)Nicola Di Trani · Houston Methodist1 papers (2020–2020)Kai Sun · Second Affiliated Hospital of Zhejiang University1 papers (2022–2022)Jesus Paez‐Mayorga · Houston Methodist1 papers (2020–2020)Jeremy Ho · Thomas Jefferson University1 papers (2020–2020)Polly Niravath · Houston Methodist1 papers (2022–2022)Sandra Demaria · Cornell University1 papers (2020–2020)